Trial Profile
Randomized Phase II Study of the Combination of Gemcitabine (Gemzar) Plus Cisplatin Single Dose Versus Split Dose in the Treatment of Patients With Locally Advanced or Metastatic Breast Cancer After Failure of Anthracyclines an/or Taxanes
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Jun 2009
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Gemcitabine (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Sponsors Eli Lilly and Company
- 05 Jun 2009 New trial record.